Doshi Dipal 4
4 · Entrada Therapeutics, Inc. · Filed Sep 4, 2025
Insider Transaction Report
Form 4
Doshi Dipal
DirectorCEO
Transactions
- Tax Payment
Common Stock
2025-09-02$5.43/sh−8,723$47,368→ 415,664 total
Footnotes (2)
- [F1]This sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of previously granted RSUs.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.36 to $5.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.